Feds End Bristol-Myers FCPA Probe After $14M SEC Fine
The U.S. Department of Justice has ended an inquiry into allegations that Bristol-Myers Squibb Co. violated the Foreign Corrupt Practices Act by paying bribes in China, the company has announced, weeks...To view the full article, register now.
Already a subscriber? Click here to view full article